(Q45423041)

English

Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice (English)

1 reference

Europe PubMed Central

14 December 2017

author name string

Hovden AO

1

1 reference

Europe PubMed Central

14 December 2017

Cox RJ

2

1 reference

Europe PubMed Central

14 December 2017

Madhun A

3

1 reference

Europe PubMed Central

14 December 2017

Haaheim LR

4

1 reference

Europe PubMed Central

14 December 2017

publication date

1 October 2005

1 reference

Europe PubMed Central

14 December 2017

Scandinavian Journal of Immunology

1 reference

Europe PubMed Central

14 December 2017

62

1 reference

Europe PubMed Central

14 December 2017

342-352

1 reference

Europe PubMed Central

14 December 2017

4

1 reference

Europe PubMed Central

14 December 2017

Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

A Controlled Double-Blind Comparison of Reactogenicity, Immunogenicity, and Protective Efficacy of Whole-Virus and Split-Product Influenza Vaccines in Children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

IgM and IgG Antibody Responses after Immunization of Children with Inactivated Monovalent (A/New Jersey/76) and Bivalent (A/New Jersey/76-A/Victoria/75) Influenza Virus Vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Developing vaccines against pandemic influenza

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Confronting the avian influenza threat: vaccine development for a potential pandemic.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Virus-specific CD8+ T cells in primary and secondary influenza pneumonia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Origin and homing of intestinal IgA antibody-secreting cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Respiratory vaccination of mice against influenza virus: dissection of T- and B-cell priming functions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Humoral and cell-mediated immunity to vero cell-derived influenza vaccine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2005.01666.X

21 January 2018

Identifiers

10.1111/J.1365-3083.2005.01666.X

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45423041&oldid=2076923047"